Altered extracellular matrix component gene expression in murine polycystic kidney

Area of Science:

• Nephrology
• Molecular Biology
• Genetics

Background:

• Polycystic kidney disease (PKD) is a genetic disorder characterized by kidney cyst formation.
• The DBA/2FG-pcy mouse model exhibits a slowly progressive kidney disease resembling human autosomal dominant PKD.
• Understanding the molecular mechanisms underlying PKD progression is crucial for developing therapeutic strategies.

Purpose of the Study:

• To investigate the regulation of extracellular matrix (ECM) component gene expression in a murine model of PKD.
• To compare ECM gene expression in DBA/2FG-pcy mice with control DBA/2 mice at different ages (8, 16, and 30 weeks).

Main Methods:

• Quantitative analysis of mRNA levels for key ECM components including collagen IV, laminin (B1 and B2 chains), heparan sulfate proteoglycan, fibronectin, and collagens I and III.
• Immunofluorescence staining to visualize the distribution of ECM proteins around kidney cysts.

Main Results:

• Significant upregulation of mRNA for collagen IV, laminin, heparan sulfate proteoglycan, fibronectin, and collagens I and III was observed with increasing cyst progression in DBA/2FG-pcy mice.
• At 30 weeks, mRNA levels for these ECM components were markedly elevated compared to controls (e.g., collagen IV increased 8.1-fold).
• Immunofluorescence revealed irregular deposition of these ECM proteins surrounding the developing cysts.

Conclusions:

• Altered expression of basement membrane components and interstitial collagens is associated with the pathogenesis of polycystic kidney disease in this mouse model.
• These ECM changes may play a significant role in the development and progression of kidney cysts in PKD.